HomeCompareNTBL vs FCPT

NTBL vs FCPT: Dividend Comparison 2026

NTBL yields 806.78% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NTBL wins by $2978922.51M in total portfolio value
10 years
NTBL
NTBL
● Live price
806.78%
Share price
$0.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2978922.56M
Annual income
$2,394,962,626,110.49
Full NTBL calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — NTBL vs FCPT

📍 NTBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNTBLFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NTBL + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NTBL pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NTBL
Annual income on $10K today (after 15% tax)
$68,576.04/yr
After 10yr DRIP, annual income (after tax)
$2,035,718,232,193.92/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, NTBL beats the other by $2,035,718,227,284.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NTBL + FCPT for your $10,000?

NTBL: 50%FCPT: 50%
100% FCPT50/50100% NTBL
Portfolio after 10yr
$1489461.30M
Annual income
$1,197,481,315,942.88/yr
Blended yield
80.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

NTBL
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
-15.3
Piotroski
1/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NTBL buys
0
FCPT buys
0
No recent congressional trades found for NTBL or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNTBLFCPT
Forward yield806.78%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$2978922.56M$49.1K
Annual income after 10y$2,394,962,626,110.49$5,775.28
Total dividends collected$2932808.83M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: NTBL vs FCPT ($10,000, DRIP)

YearNTBL PortfolioNTBL Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$91,378$80,677.69$11,401$700.92+$80.0KNTBL
2$786,759$688,985.18$13,064$864.84+$773.7KNTBL
3$6,385,891$5,544,058.49$15,051$1,072.48+$6.37MNTBL
4$48,888,484$42,055,580.67$17,442$1,337.22+$48.87MNTBL
5$353,212,577$300,901,898.82$20,340$1,677.08+$353.19MNTBL
6$2,409,689,660$2,031,752,203.28$23,880$2,116.57+$2409.67MNTBL
7$15,532,607,283$12,954,239,346.30$28,241$2,689.36+$15532.58MNTBL
8$94,658,834,336$78,038,944,543.74$33,660$3,442.07+$94658.80MNTBL
9$545,756,944,763$444,471,992,023.36$40,456$4,439.95+$545756.90MNTBL
10$2,978,922,557,007$2,394,962,626,110.49$49,063$5,775.28+$2978922.51MNTBL

NTBL vs FCPT: Complete Analysis 2026

NTBLStock

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.

Full NTBL Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this NTBL vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NTBL vs SCHDNTBL vs JEPINTBL vs ONTBL vs KONTBL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.